Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 29.32

+4.6%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeffrey L. Henken who wrote (5586)	10/17/1999 2:38:00 PM
From: Jean-Philippe Chevalier	Read Replies (1) of 5736

Mr. Chevalier is quite certain that Mr. Henken is a nut. Henken's voodoo analysis of market forces is undisputable evidence. Meanwhile, CCSI's viability as a free market entity remains in question. We can surmise that the manufacturer may make a few bucks for their role and the distributor will earn some greenbacks for their efforts. Certainly the distributor is not relying on CCSI to maintain viability and it is unlikely that the manufacturer is either. Meanwhile, CCSI adds no value to the product but hopefully will net a few shekels for their rights to the Colormate. At these levels, however, they are probably taking it in the shorts. Only if we make a quantum leap from the current limited acceptance in product demand to significant market saturation could we expect CCSI to show profitability. That would be making a huge assumption that the manufacturing and marketing agreements weren't botched in an effort to get positive press releases out in order to continue supporting the stock price as this company is burning resources at astronomical rates considering that revenues are essentially zilch. Jean-Philippe knows of a similar product, a confirmed technological advance that was never successfully brought to market due to the acceptance of the existing technology. The product was a hollow shaft "bleeding" arrow. When a bow hunter would slam the high tech arrow into a beast of burden, the hollow shaft would enhance the bleeding or in the case of a lung shot, it would collapse the lung straight away. This more humane sticking process would kill the animal quicker, often right in its tracks, rather than having the animal limp off into the woods to die a slow and painful death. So it remains to be seen if CCSI can successfully bring their product to market in any meaningful way. Meanwhile, Jean-Philippe values the stock at somewhere under a buck. If one really wanted to play this venture, it would seem that investing in the distributor would make a lot more sense.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next